Abstract
Objective. To study the effect of mutations of genes responsible for the development of familial hypercholesterolemia (FH) and lipid profile on the structural and morphological state of blood vessels based on the intima-media thickness (IMT) of the common carotid artery in children with heterozygous familial hypercholesterolemia.
Material and methods. The study was conducted in the period from 2019 to 2023 and included 214 children aged 2 to 17 years. The comparison group consisted of 107 children. The main group included 107 patients diagnosed with “familial hypercholesterolemia, heterozygous form”, who were divided into 3 groups depending on the phenotype and genotype of the disease: 2 – children with a positive phenotype and with identified mutations associated with FH: LDLR, APOB, PCSK9, LDLRAP1; 3 – children with a positive phenotype, but no identified mutations; 4 – children with a negative phenotype and a positive genotype.
All children underwent clinical and laboratory diagnostics, ultrasound of the neck vessels with an assessment of the IMT of the common carotid artery. Patients of the main group underwent next-generation sequencing using a gene panel: LDLR, APOB, PCSK9, LDLRAP1.
Results. In patients of groups 2 and 3, statistically significant increase in total cholesterol (TC), low-density lipoproteins (LDL) and IMT values was revealed relative to the comparison group. IMT values were significantly higher in children of group 2 relative to group 3, while lipid indices did not differ. In group 4, LDL and IMT values were significantly lower than similar indices in group 2.
The most common LDLR variants were: c.986G>A, c.906C>G, c.1187-10G>A. The increase in IMT was significantly higher in patients with c.1187-10G>A relative to c.906C>G.
Conclusion. Patients with FH were characterized by increased levels of TC, LDL and thickened IMC in contrast to healthy peers. In children with identified mutations in genes associated with FH, signs of vascular remodeling were established from the age of 8 years, compared with children with phenotypic FH.
The obtained results emphasize the importance of early diagnosis, including genetic, and continuous monitoring of the vascular wall condition of patients with FH to prevent progression.
References
- Russian statistical yearbook 2022: statistical collection. Moscow; 2022 (in Russ.). Available at: https://rosstat. gov.ru/storage/mediabank/Ejegodnik_2022.pdf (accessed 20.09.2024).
- Wiegman A., Gidding S.S., Watts G.F., Chapman M.J., Ginsberg H.N., Cuchel M. et al. European Atherosclerosis Society Consensus Panel. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment. Eur. Heart J. 2015; 36 (36): 2425–2437. DOI: 10.1093/eurheartj/ehv157
- Filippov E.V., Jakushin S.S., Petrov V.S. Dyslipidemias and their associations with chronic non-communicable diseases (MERIDIAN-RO study). The Clinician. 2016; 10 (3): 32–40 (in Russ.). DOI: 10.17650/1818-8338-2016-10-3-32-40
- Metelskaya V.A., Shalnova S.A., Deev A.D., Perova N.V., Gomyranova N.V., Litinskaya O.A. et al. Analysis of atherogenic dyslipidemias prevalence among population of Russian Federation (results of the ESSE-RF Study). Russian Journal of Preventive Medicine. 2016; 19 (1): 15–23 (in Russ.). DOI: 10.17116/profmed201619115-23
- Kit B., Kuklina E., Carroll M., Ostchega Y., Freedman D., Ogden C. Prevalence of and trends in dyslipidemia and blood pressure among US children and adolescents, 1999–2012. JAMA Pediatrics. 2015; 169 (3): 272–279. DOI: 10.1001/jamapediatrics.2014.3216
- Ding W., Dong H., Mi J. Prevalence of dyslipidemia in Chinese children and adolescents: a meta-analysis. Zhon-ghua Liu Xing Bing Xue Za Zhi. 2015; 36 (1): 71–77. DOI: 10.3760/CMA.J.ISSN.0254-6450.2015.01.017
- Shah N., Khadilkar A., Gondhalekar K., Khadilkar V. Prevalence of dyslipidemia in Indian children with poorly controlled type 1 diabetes mellitus. Pediatr. Diabetes. 2020; 21 (6): 987–994. DOI: 10.1111/pedi.13063
- Hovsepian S., Kelishadi R., Djalalinia S., Farzadfar F., Naderimagham S., Qorbani M. Prevalence of dyslipidemia in Iranian children and adolescents: a systematic review. J. Res. Med. Sci. 2015; 20 (5): 503–521. DOI: 10.4103/1735-1995.163979
- Clinical guidelines. Familial hypercholesterolemia. Ministry of Health of the Russian Federation. Moscow; 2018 (in Russ.). Available at: https://noatero.ru/sites/default/files/proekt_klinicheskie_rekomendacii_sghs_mz_rf_18.01.pdf (accessed 20.09.2024).
- Beheshti S.O., Madsen C.M., Varbo A., Nordestgaard B.G. Worldwide prevalence of familial hypercholesterolemia: meta-analyses of 11 million subjects. J. Am. Coll. Cardiol. 2020; 75 (20): 2553–2566. DOI: 10.1016/j.jacc.2020.03.057
- Yezhov M.V., Barbarash O.L., Voevoda M.I., Gurevich V.S., Vezikova N.N., Sadykova D.I. et al. Organization of the work of lipid centers in the Russian Federation – new opportunities. Project of the National Society for the Study of Atherosclerosis (NOA). Russian Journal of Cardiology. 2021; 26 (6): 4489 (in Russ.). DOI: 10.15829/1560-4071-2021-4489
- Ershova A.I., Meshkov A.N., Bazhan S.S., Storozhok M.A., Efanov A.Y., Medvedeva I.V. et al. The prevalence of familial hypercholesterolemia in the West Siberian region of the Russian Federation: a substudy of the ESSE-RF. PLoS One. 2017; 12 (7): e0181148. DOI: 10.1371/journal. pone. 0181148
- Tokgozoglu L., Kayikcioglu M. Familial hypercholesterolemia: global burden and approaches. Curr. Cardiol. Rep. 2021; 23 (10): 151. DOI: 10.1007/s11886-021-01565-5
- Kusters D.M., Wiegman A., Kastelein J.J., Hutten B.A. Carotid intima-media thickness in children with familial hypercholesterolemia. Circ. Res. 2014; 114 (2): 307–310. DOI: 10.1161/CIRCRESAHA.114.301430
- Leontyeva I.V. Modern strategy for diagnosis and treatment of familial heterozygous hypercholesterolemia in children. Russian Bulletin of Perinatology and Pediatrics. 2020; 65 (4): 27–40 (in Russ.). DOI: 10.21508/1027-4065-2020-65-4-27-40
- Galimova L.F., Sadykova D.I., Slastnikova E.S., Khaliullina Ch.D., Salakhova K.R. Three-year prospective observation of patients with heterozygous familial hypercholesterolemia in childhood: focus on predictors of vascular remodeling. Atherosclerosis and Dyslipidemia. 2024; 55: 41–51 (in Russ.). DOI: 10.34687/2219-8202.JAD.2024.02.0005
- Stein J.H., Korcarz C.E., Hurst R.T., Lonn E., Kendall C.B., Mohler E.R. et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J. Am. Soc. Echocardiogr. 2008; 21 (4): 376. DOI: 10.1016/j. echo.2007.11.011
- Kovacs B., Cseprekal O., Dioszegi A., Lengyel S., Maroda L., Paragh G. et al. The Importance of arterial stiffness assessment in patients with familial hypercholesterolemia. J. Clin. Med. 2022; 11 (10): 2872. DOI: 10.3390/jcm11102872
About the authors
- Dinara I. Sadykova, Dr. Med. Sci., Professor, Chief of Chair of Hospital Pediatrics1, Leading Researcher2; ORCID
- Chulpan D. Khaliullina, Postgraduate, Pediatric Cardiologist; ORCID
- Liliya F. Galimova, Dr. Med. Sci., Associate Professor of Chair of Hospital Pediatrics, Head of Department of Ultrasound Diagnostics; ORCID
- Evgeniya S. Slastnikova, Cand. Med. Sci., Assistant Professor1, Researcher2, Pediatric Cardiologist; ORCID
- Elena I. Shagimardanova, Cand. Biol. Sci., Associate Professor of Chair of Zoology and General Biology; ORCID
- Leyla Kh. Shigapova, Senior Researcher; ORCID
- Karina R. Salakhova, Postgraduate1, Laboratory Assistant-Researcher2; ORCID
